Analyst Ratings for Talis Biomedical Corp. (tlis)

tlis Rating Summary

  |   Expand Research on tlis
Overall Rating: SELL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/18/2022 BTIG
» Updated 8/16/2023		 Mark A. Massaro Downgrade Sell
(Neutral)		 5.00
(0.35)		 1.42
(4.38)		 208.45% Details
1/7/2022 BofA Securities Derik de Bruin Downgrade Underperform
(Neutral)		 3.00
(N/A)		 3.53
(4.38)		 24.08% Details